Bransjer
- Finans
- Fiskeri og havbruk
- Forbrukerstoff
- Hjem og interiør
- Hotell og restaurant
- Hus og hage
- Industri
- Internasjonale
- Internett, reklame og media
- IT og telekom
- Kontor og data
- Legemidler og helse
- Mat og ernæring
- Miljø og Energi
- Motor og båt
- Offentlige organisasjoner
- Organisasjoner
- Reiser, fritid, kultur
- Sport, klær og mote
- Utdanning
07.08.2012 21:27:00
Equity Briefing: AMRI Second Quarter Earnings CorrectionLast week, Equity Briefing incorrectly reported that Albany Molecular Research (NASDAQ: AMRI) reported $0.01 earnings per share for the second quarter. Albany Molecular Research's actual earnings were $0.06 per share for the second quarter, beating the Thomson Reuters Consensus estimate of $0.02 by $.04. This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Equity Briefing via Thomson Reuters ONE [HUG#1632490] |
